Neonatology News and Research

RSS

Women & Infants Hospital awarded $5 million NIH grant to support COBRE for Perinatal Biology

Women & Infants Hospital of Rhode Island has recently received a nearly $5 million grant from the National Institutes of Health to support an Institutional Development Award Center of Biomedical Research Excellence for Perinatal Biology.

4 Jun 2015

New way to evaluate brainstorms in newborn very premature infants

Giant strides have been taken in the early care of very premature infants in postnatal intensive care units during the past two decades. Doctors can now support the function of especially the lungs, heart and the circulatory system so as to guarantee the survival of most of even extremely premature infants.

1 Jun 2015

Researchers create 'brainstorm barometer' to calculate the brain functions of very premature infants

University of Helsinki researchers have partnered with Swedish and Australian researchers to create a "brainstorm barometer", which allows computers to calculate the brain functions of very premature babies during their first hours of life.

25 May 2015

Gynecologic oncologist awarded grant to improve quality of life for women with endometrial cancer

The Patient-Centered Outcomes Research Institute Board of Governors recently awarded more than $2.7 million in contracted funding to Katina Robison, MD, a gynecologic oncologist with the Program in Women's Oncology at Women & Infants Hospital of Rhode Island, a Care New England hospital, for the study "Cancer of the Uterus and Treatment of Stress Incontinence."

8 May 2015

Study finds hospital variation in outcomes for extremely premature infants

Extremely premature infants born at 22 to 25 weeks of gestation have low rates of survival, and many of those infants who live have severe or moderate neurodevelopmental impairments. Thus, clinicians and families face the extremely difficult decision to either provide active, potentially lifesaving treatment at birth, or just provide comfort care.

7 May 2015

Neonatal abstinence syndrome on the rise in U.S.

The number of infants born in the United States with drug withdrawal symptoms, also known as neonatal abstinence syndrome (NAS), nearly doubled in a four-year period. By 2012, one infant was born every 25 minutes in the U.S. with the syndrome, accounting for $1.5 billion in annual health care charges, according to a new Vanderbilt study published in the Journal of Perinatology.

30 Apr 2015

DFG Senate approves establishment of one Clinical Research Unit, five Research Units

At its spring meeting in Bonn, the Senate of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) approved the establishment of one new Clinical Research Unit and five new Research Units.

30 Mar 2015

UF Health Cancer Center - Orlando Health recognized as one of America's Best Breast Centers

UF Health Cancer Center - Orlando Health earns the 2015 Women's Choice Award as one of America's Best Breast Centers, acknowledging its dedication to providing exceptional patient care and treatment.

17 Mar 2015

Researchers discover gene associated with congenital anomaly of urinary tract

An interdisciplinary team of researchers under the direction of the University of Bonn Hospital have discovered a gene which is associated with a rare congenital anomaly of the urinary tract called classic bladder exstrophy.

13 Mar 2015

New Nationwide Children's app aims to help make homes safer for children

Nationwide Children's Hospital is joining Nationwide - one of the largest and strongest diversified insurance and financial services organizations in the U.S. - in their effort to prevent childhood injury. According to the Centers for Disease Control and Prevention, and many injuries occur in and around the home. Through this new Make Safe Happen initiative, Nationwide Children's researchers developed a new Make Safe Happen app to help prevent childhood injury.

12 Mar 2015

Inhaled Nitric Oxide still being used in preterm neonates despite evidence of short-term benefit

Inhaled Nitric Oxide (iNO) is a drug approved by the Food and Drug Administration that is commonly used in term and near-term neonates who have severe respiratory failure caused by pulmonary hypertension. Over the last decade there have been multiple large studies trying to determine a clinical use for iNO in preterm neonates, but despite evidence of short-term benefit, this drug has not been shown to improve long-term outcomes in preemies.

10 Mar 2015

Study: Infant gut microbiota associated with healthy weight gain

Researchers in Singapore and UK as part of the EpiGen consortium worked together with scientists at the Nestlé Research Center, Switzerland, on a new study on the bacterial makeup of the gut (gut microbiota) of infants in Singapore. Their study reveals that the rate of bacterial colonisation of the gut is influenced by external factors such as the method of delivery and duration of gestation.

5 Feb 2015

Women & Infants Hospital of Rhode Island receives 2015 Women's Choice Award

Today it was announced that Women & Infants Hospital of Rhode Island, a Care New England Hospital, has received the 2015 Women's Choice Award as one of America's Best Hospitals for Obstetrics. This evidence-based designation identifies the country's best health care institutions based on robust criteria that consider female patient satisfaction, clinical excellence and what women say they want from a hospital.

14 Jan 2015

Orlando Regional Medical Center opens new patient tower

As the new year begins, Orlando Health turns the page to a new chapter in patient, guest and team member experience, when Orlando Regional Medical Center opens its new patient tower.

9 Jan 2015

Loyola to be included in "Guinness World Records" 2015 edition for neonatal care

Loyola University Medical Center will be included in the "Guinness World Records" 2015 edition for caring for the world's smallest baby.

2 Jan 2015

Two-drug combination before surgery benefits women with triple-negative breast cancer

A breast cancer specialist and clinical researcher at Women & Infants Hospital of Rhode Island presented research yesterday at the 2014 San Antonio Breast Cancer Symposium showing that adding either the chemotherapy drug carboplatin or the blood vessel-targeting drug bevacizumab to the standard treatment of chemotherapy before surgery helped women who have the basal-like subtype of triple-negative breast cancer.

15 Dec 2014

Multiple factors influence survival of extremely premature infants

Multiple factors influence how well a severely premature infant (23 weeks gestation) will do after birth and over the long-term, according to researchers at Loyola University Chicago Stritch School of Medicine. These findings were published in the latest issue of the American Journal of Perinatology.

10 Dec 2014